XML 16 R12.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Income Per Common Share
6 Months Ended
Jun. 30, 2011
Income Per Common Share [Abstract]  
Income Per Common Share
Note 6: Income Per Common Share

   
For three months ended June 30, 2011
  
For six months ended June 30, 2011
 
   
Income Available to Common Shareholders
  
Average Common Shares Outstanding
  
Per Common Share
  
Income Available to Common Shareholders
  
Average Common Shares Outstanding
  
Per Common Share
 
Basic Income Per Common Share
 $508,152   2,672,325  $0.19  $749,723   2,670,675  $0.28 
Effect of Dilutive Securities
      29,712           23,562     
Diluted Income Per Common Share
 $508,152   2,702,037  $0.19  $749,723   2,694,237  $0.28 

   
For three months ended June 30, 2010
  
For six months ended June 30, 2010
 
   
Income Available to Common Shareholders
  
Average Common Shares Outstanding
  
Per Common Share
  
Income Available to Common Shareholders
  
Average Common Shares Outstanding
  
Per Common Share
 
Basic Income Per Common Share
 $211,113   2,641,277  $0.08  $405,588   2,638,932  $0.15 
Effect of Dilutive Securities
      37,972           16,751     
Diluted Income Per Common Share
 $211,113   2,679,249  $0.08  $405,588   2,655,683  $0.15 

Stock options to purchase 304,329 and 334,579 shares of common stock were outstanding during the three months ended June 30, 2011and 2010, respectively, and stock options to purchase 361,829 and 334,579 shares of common stock were outstanding during the six months ended June 30, 2011and 2010, respectively, but were not included in the computation of diluted income per common share because their exercise prices were greater than the average market price of the common shares.   Stock warrants to purchase 459,459 shares of common stock were outstanding during the three and six months ended June 30, 2011 and 2010, and were included in the computation of diluted income per common share because their exercise price was less than the average market price of the common shares during those periods.